NU-6027
CAS No. 220036-08-8
NU-6027 ( NU6027;NU 6027 )
Catalog No. M13509 CAS No. 220036-08-8
NU-6027 (NU6027) is an ATP-competitive inhibitor of CDK1 and CDK2 with Ki of 2.5 uM and 1.3 uM respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 34 | Get Quote |
|
5MG | 55 | Get Quote |
|
10MG | 91 | Get Quote |
|
25MG | 186 | Get Quote |
|
50MG | 295 | Get Quote |
|
100MG | 441 | Get Quote |
|
500MG | 981 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNU-6027
-
NoteResearch use only, not for human use.
-
Brief DescriptionNU-6027 (NU6027) is an ATP-competitive inhibitor of CDK1 and CDK2 with Ki of 2.5 uM and 1.3 uM respectively.
-
DescriptionNU-6027 (NU6027) is an ATP-competitive inhibitor of CDK1 and CDK2 with Ki of 2.5 uM and 1.3 uM respectively; inhibits human tumor cells with a mean GI50 of 10 ±6 uM; also inhibits cellular ATR (IC50=6.7 uM) and RAD51 focus formation, increases the cytotoxicity of the major classes of DNA-damaging anticancer cytotoxic therapy.
-
SynonymsNU6027;NU 6027
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorATR;CDK1;CDK2;DNA-PK
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number220036-08-8
-
Formula Weight251.30
-
Molecular FormulaC11H17N5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 47 mg/mL (187 mM); Ethanol: 3 mg/mL (11.93 mM); Water: <1 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESNC1=NC(OCC2CCCCC2)=C(N=O)C(N)=N1
-
Chemical Name6-(cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Arris CE, et al. J Med Chem. 2000 Jul 27;43(15):2797-804.
2. Peasland A, et al. Br J Cancer. 2011 Jul 26;105(3):372-81.
3. Boschi D, et al. Eur J Med Chem. 2013 Oct;68:333-8.
2. Peasland A, et al. Br J Cancer. 2011 Jul 26;105(3):372-81.
3. Boschi D, et al. Eur J Med Chem. 2013 Oct;68:333-8.
molnova catalog
related products
-
HQ461
HQ461 is a molecular glue that promotes CDK12-DDB1 interaction to trigger cyclin K degradation, resulting in decreased CDK12 substrate phosphorylation, downregulation of DNA damage response genes, and cell death.
-
BML-259
BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.
-
Palbociclib hydrochl...
A potent and selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM; no inhibition for CDK2A (IC50>5 uM); inhibits MDA-MB453 cells with IC50 of 0.16 uM.